Personalized Treatment for Patients With Premature Ventricular Beats
1 other identifier
observational
224
1 country
1
Brief Summary
Frequent premature ventricular beats (PVBs) are common, negatively affects the quality of life for many patients, and can lead to impaired contractile function. Rule-out of structural heart disease is key in the assessment of PVBs. Cardiac MR has a high sensitivity for structural heart disease, but the diagnostic gain from this resource-demanding procedure in the work-up of patients with PVBs is unknown. There is a need to establish the role of MR in the evaluation of patients with PVBs to improve diagnostic efficacy, establish treatment strategies, and promote further research. This project will answer three key questions: 1) What is the diagnostic gain from cardiac MR in patients with PVBs? 2) Is MR the real gold standard to rule-out structural heart disease in patients with PVBs? 3) Can non-invasive heart rate parameters guide the strategy for induction of PVBs during invasive electrophysiological procedures?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 30, 2020
CompletedFirst Submitted
Initial submission to the registry
October 26, 2020
CompletedFirst Posted
Study publicly available on registry
November 5, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2040
ExpectedNovember 2, 2023
October 1, 2023
3.8 years
October 26, 2020
October 31, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
MRI-based evidence of structural heart disease
Evidence of structural heart disease from MRI compared to echocardiography
3-5 years
PVC induction vs PVC/HR-relationship
Correlation of method for induction of PVCs during invasive procedure vs PVC/HR relationship during CPET
3-5 years
EPS-based evidence of structural heart disease
Evidence of structural heart disease from invasive electrophysiology vs MRI and echo
3-5 years
Interventions
Invasive cardiac electrophysiological study with cathecholamine provocation and pacing procedures, as well as standard 3D mapping and PVC ablation
Standard ergometer bicycle test
Cardiac MRI with cine-imaging and late-gadolinium enhancement
24h 5 lead or 12 lead ECG recording
2D echocardiography
Conventional invasive coronary angiography or CT angiography as indicated
Eligibility Criteria
Patients referred to PVC ablation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- University of Oslocollaborator
Study Sites (1)
Oslo University Hospital
Oslo, 0672, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mathis K Stokke, MD PhD
Oslo University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor and Consultant Cardiologist
Study Record Dates
First Submitted
October 26, 2020
First Posted
November 5, 2020
Study Start
September 30, 2020
Primary Completion
June 30, 2024
Study Completion (Estimated)
July 31, 2040
Last Updated
November 2, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share